Plauth M, Schneider B H, Raible A, Hartmann F
Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Humboldt-Universität Berlin, Germany.
Int J Colorectal Dis. 1999 Apr;14(2):95-100. doi: 10.1007/s003840050192.
This study examined whether the route of glutamine administration and the simultaneous availability of glucose affect intestinal glutamine metabolism. We measured net substrate exchange rates of glutamine and its nitrogenous products in the isolated vascularly and luminally perfused rat small intestine (a) as a function of glutamine provision from either the vascular or the luminal or simultaneously from both sides and (b) as a function of simultaneous availability of glucose from various routes. When glutamine was provided from the lumen, only 19-32% of absorbed glutamine appeared intact in the venous effluent, but the release of metabolic products was 170 +/- 5 nmol N min-1 g-1. This measure of intestinal glutamine metabolism was unchanged when glutamine was available only in the vascular perfusate (164 +/- 6 nmol N min-1 g-1). It increased, however, to 271 +/- 14 nmol N min-1 g-1 (P < 0.001) when glutamine was available simultaneously from both the luminal and the vascular perfusate. Glutamine consumption (-110 +/- 6 vs. -70 +/- 5 or -91 +/- 5 vs. -73 +/- 7 nmol min-1 g-1; P < 0.05 each) and the production of citrulline (11.4 +/- 0.7 vs. 10.0 +/- 0.8 or 9.8 +/- 0.5 vs. 7.8 +/- 0.4 nmol min-1 g-1; P < 0.05 each) or ammonia (124 +/- 7 vs. 88 +/- 4; P < 0.01 or 78 +/- 4 vs. 68 +/- 5 nmol min-1 g-1) decreased when glucose (vascular or luminal perfusate) became available in addition to glutamine. We conclude that glutamine is utilized by the small intestine very efficiently regardless of the route of administration being enteral or parenteral. The two routes can be used interchangeably to provide the intestinal mucosa with glutamine. Glucose and glutamine may partially substitute each other, most likely for the purpose as a metabolic fuel.
本研究探讨了谷氨酰胺的给药途径以及葡萄糖的同时可用性是否会影响肠道谷氨酰胺代谢。我们测量了在离体的经血管和肠腔灌注的大鼠小肠中谷氨酰胺及其含氮产物的净底物交换率:(a) 作为从血管或肠腔或同时从两侧提供谷氨酰胺的函数;(b) 作为从各种途径同时提供葡萄糖的函数。当从肠腔提供谷氨酰胺时,只有19% - 32%被吸收的谷氨酰胺完整地出现在静脉流出物中,但代谢产物的释放量为170±5 nmol N min⁻¹ g⁻¹。当谷氨酰胺仅存在于血管灌注液中时,这种肠道谷氨酰胺代谢的指标没有变化(164±6 nmol N min⁻¹ g⁻¹)。然而,当谷氨酰胺同时从肠腔和血管灌注液中提供时,它增加到271±14 nmol N min⁻¹ g⁻¹(P < 0.001)。当除了谷氨酰胺之外还提供葡萄糖(血管或肠腔灌注液)时,谷氨酰胺的消耗(-110±6对-70±5或-91±5对-73±7 nmol min⁻¹ g⁻¹;每组P < 0.05)以及瓜氨酸(11.4±0.7对10.0±0.8或9.8±0.5对7.8±0.4 nmol min⁻¹ g⁻¹;每组P < 0.05)或氨(124±7对88±4;P < 0.01或78±4对68±5 nmol min⁻¹ g⁻¹)的生成减少。我们得出结论,无论给药途径是肠内还是肠外,小肠都能非常有效地利用谷氨酰胺。这两种途径可以互换使用,为肠黏膜提供谷氨酰胺。葡萄糖和谷氨酰胺可能部分相互替代,最有可能是作为代谢燃料。